| Line Item | Jul 31, 2026 | Apr 30, 2026 | Jul 31, 2025 | Apr 30, 2025 |
|---|---|---|---|---|
| OPERATING EXPENSES | ||||
| Advertising and promotion | ||||
| Depreciation and amortization | ||||
| Bank charges | ||||
| Business development | ||||
| Consulting | ||||
| Filing and listing fees | ||||
| Insurance | ||||
| Investor relations | ||||
| Management and directors' salaries and fees - related parties | ||||
| Office and general administrative | ||||
| Professional fees | ||||
| Regulatory fees | — | |||
| Research and development | ||||
| Total operating expenses | ||||
| LOSS FROM OPERATIONS | ||||
| OTHER INCOME (EXPENSES) | ||||
| Gain on conversion of payables | ||||
| Write-off of deferred offering costs | — | |||
| Interest income | ||||
| Interest expense | ||||
| Foreign exchange gain (loss) | ||||
| Total other income (expenses) | ||||
| LOSS BEFORE TAXES | ||||
| Income tax benefit (expense) | ||||
| NET LOSS | ||||
| Net loss per common share, basic | ||||
| Net loss per common share, diluted |